![Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/7762d38f-8b7a-4b5c-a44f-5a4bc7cca2a3/gr1.gif)
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry
![Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1016%2FS0893-133X%2802%2900375-5/MediaObjects/41386_2002_Article_BF1395965_Fig1_HTML.jpg)
Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology
![Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital | Schizophrenia Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital | Schizophrenia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41537-020-00122-3/MediaObjects/41537_2020_122_Fig1_HTML.png)